| Item Type | Name |
|
Academic Article
|
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells.
|
|
Academic Article
|
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Lymphatic Metastasis
|
|
Academic Article
|
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.
|
|
Academic Article
|
Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
|
|
Academic Article
|
Molecular targets for treatment of inflammatory breast cancer.
|
|
Academic Article
|
Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis.
|
|
Academic Article
|
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
|
|
Academic Article
|
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer.
|
|
Academic Article
|
Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors.
|
|
Academic Article
|
Prognostic value of nodal ratios in node-positive breast cancer.
|
|
Academic Article
|
The future of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy.
|
|
Academic Article
|
Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer.
|
|
Academic Article
|
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
|
|
Academic Article
|
Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.
|
|
Academic Article
|
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.
|
|
Academic Article
|
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.
|
|
Academic Article
|
HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation.
|
|
Academic Article
|
Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.
|
|
Academic Article
|
Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer.
|
|
Academic Article
|
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.
|
|
Academic Article
|
Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients.
|
|
Academic Article
|
Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.
|
|
Academic Article
|
Metastasis in the breast mimicking inflammatory breast cancer.
|
|
Academic Article
|
The role of inflammation in inflammatory breast cancer.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for metastatic breast cancer.
|
|
Academic Article
|
Prognostic value of nodal ratios in node-positive breast cancer: a compiled update.
|
|
Academic Article
|
Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model.
|
|
Academic Article
|
Incidence of and survival following brain metastases among women with inflammatory breast cancer.
|
|
Academic Article
|
Serum HER2 levels determined by two methods in patients with metastatic breast cancer.
|
|
Academic Article
|
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
|
|
Academic Article
|
FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer.
|
|
Academic Article
|
High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
|
|
Academic Article
|
Chromosome 17 polysomy in circulating tumor cells in patients with metastatic breast cancer: a case series.
|
|
Academic Article
|
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.
|
|
Academic Article
|
Latest biopsy approach for suspected metastases in patients with breast cancer.
|
|
Academic Article
|
A hepatocellular carcinoma with lymph node metastasis and invasion into the gallbladder: preoperative difficulty ruling out a gallbladder carcinoma.
|
|
Academic Article
|
Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus.
|
|
Academic Article
|
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.
|
|
Academic Article
|
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.
|
|
Academic Article
|
Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.
|
|
Academic Article
|
Gene signature-guided dasatinib therapy in metastatic breast cancer.
|
|
Academic Article
|
Clinical characteristics and outcome of bone-only metastasis in inflammatory and noninflammatory breast cancers.
|
|
Academic Article
|
Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
|
|
Academic Article
|
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
|
|
Academic Article
|
Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
|
|
Academic Article
|
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.
|
|
Academic Article
|
MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.
|
|
Academic Article
|
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
|
|
Academic Article
|
Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction.
|
|
Academic Article
|
miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.
|
|
Academic Article
|
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer.
|
|
Academic Article
|
Bone metastases
|
|
Academic Article
|
Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis
|
|
Academic Article
|
Bone metastasis of breast cancer
|
|
Academic Article
|
Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma
|
|
Academic Article
|
MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model
|
|
Academic Article
|
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
|
|
Academic Article
|
Inflammation mediated metastasis
|
|
Academic Article
|
miR-141-mediated regulation of brain metastasis from breast cancer
|
|
Academic Article
|
Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a
|
|
Academic Article
|
Cancer response criteria and bone metastases
|
|
Academic Article
|
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer.
|
|
Academic Article
|
Impact of clinical trial on survival outcomes.
|
|
Academic Article
|
Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy.
|
|
Academic Article
|
Clinical outcomes based on multigene profiling in metastatic breast cancer patients.
|
|
Academic Article
|
Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status.
|
|
Academic Article
|
In response to "outcomes of patients with inflammatory breast cancer treated by breast conserving surgery": the argument against breast conservation and sentinel lymph node biopsy in IBC.
|
|
Academic Article
|
Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.
|
|
Academic Article
|
Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
|
|
Academic Article
|
Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast?Cancer.
|
|
Academic Article
|
Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.
|
|
Academic Article
|
Development of CNS metastases and survival in patients with inflammatory breast cancer.
|
|
Academic Article
|
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway.
|
|
Academic Article
|
Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis.
|
|
Academic Article
|
Inflammatory breast cancer biology: the tumour microenvironment is key.
|
|
Academic Article
|
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
|
|
Academic Article
|
Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.
|
|
Academic Article
|
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
|
|
Academic Article
|
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment.
|
|
Academic Article
|
Bone Metastasis of Breast Cancer.
|
|
Academic Article
|
Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis.
|
|
Academic Article
|
Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.
|
|
Academic Article
|
Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.
|
|
Academic Article
|
Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis.
|
|
Academic Article
|
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer.
|
|
Academic Article
|
Estrogen Receptor ?-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer.
|
|
Academic Article
|
Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy.
|
|
Academic Article
|
Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
|
|
Academic Article
|
NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.
|
|
Academic Article
|
A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer.
|
|
Academic Article
|
Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis.
|
|
Academic Article
|
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.
|
|
Academic Article
|
Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer.
|